These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Atrial septal defect closure on cardiopulmonary bypass in a sickle cell anemia: role of hydroxyurea and partial exchange transfusion. Gosavi KS; Dash SK; Shah BN; Upasani CB Ann Card Anaesth; 2010; 13(2):145-7. PubMed ID: 20442545 [TBL] [Abstract][Full Text] [Related]
5. Management of patients with sickle cell disease. Pollack S JAMA; 2015 Jan; 313(1):90-1. PubMed ID: 25562273 [No Abstract] [Full Text] [Related]
7. Management of patients with sickle cell disease--reply. Yawn BP; Buchanan G; Hassell K JAMA; 2015 Jan; 313(1):91-2. PubMed ID: 25562275 [No Abstract] [Full Text] [Related]
8. Sickle cell disease in North Europe. Howard J; Davies SC Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983 [TBL] [Abstract][Full Text] [Related]
9. Sickle cell disease. Ware RE; de Montalembert M; Tshilolo L; Abboud MR Lancet; 2017 Jul; 390(10091):311-323. PubMed ID: 28159390 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic advances in sickle cell disease in the last decade. Shet AS; Thein SL Indian J Med Res; 2017 Jun; 145(6):708-712. PubMed ID: 29067969 [No Abstract] [Full Text] [Related]
11. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083 [TBL] [Abstract][Full Text] [Related]
12. The challenge of creating an evidence-based guideline for sickle cell disease. DeBaun MR JAMA; 2014 Sep; 312(10):1004-5. PubMed ID: 25203081 [No Abstract] [Full Text] [Related]
13. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Wang WC Curr Opin Hematol; 2007 May; 14(3):191-7. PubMed ID: 17414206 [TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia. Ware RE; Steinberg MH; Kinney TR Am J Hematol; 1995 Oct; 50(2):140-3. PubMed ID: 7572993 [No Abstract] [Full Text] [Related]
16. Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia. Brousse V; Gandhi S; de Montalembert M; Height S; Dick MC; O'Driscoll S; Abihsera G; Rees DC Br J Haematol; 2013 Jan; 160(2):259-61. PubMed ID: 23116405 [No Abstract] [Full Text] [Related]
17. Current issues in blood transfusion for sickle cell disease. Wahl S; Quirolo KC Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238 [TBL] [Abstract][Full Text] [Related]
18. Principles and indications of chronic transfusion therapy for children with sickle cell disease. Ware R Clin Adv Hematol Oncol; 2007 Sep; 5(9):686-8. PubMed ID: 17982409 [No Abstract] [Full Text] [Related]
19. Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry. Gilmore A; Cho G; Howard J; Layton M; Afif M; Hughes RG; Philpott NJ; Patankar S; Davies SC; Am J Hematol; 2011 Nov; 86(11):958-61. PubMed ID: 21948113 [No Abstract] [Full Text] [Related]